Articles From: Acorda Therapeutics to Present at the Stifel 2014 Healthcare Conference to Actavis and Allergan Announce Early Termination of Hart-Scott-Rodino Waiting Period for Actavis' Pending Acquisition of Allergan and Record Dates for Shareholder Meetings


Acorda Therapeutics, Inc. (Nasdaq: ACOR ) today announced that Ron Cohen, M.D., President and Chief Executive Officer will present at the Stifel 2014 Healthcare Conference on Tuesday, November 18 at 1:50pm ET.
Sign-up for Acorda Therapeutics to Present at the Stifel 2014 Healthcare Conference investment picks
Acorda Therapeutics, Inc. (Nasdaq: ACOR ) today announced that Ron Cohen, M.D., President & CEO, will present at the 33 rd Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2015 at 11:00 a.m. Pacific Time at the Westin St.
Sign-up for Acorda to Present at the 33rd Annual J.P. Morgan Healthcare Conference investment picks
WILMINGTON, Del.
Sign-up for Acorn Energy Announces Receipt of Nasdaq Notice of Bid Price Deficiency investment picks
WILMINGTON, Del.
Sign-up for Acorn Energy Announces Third Quarter and Nine Month 2014 Results investment picks
SHANGHAI , Nov.
Sign-up for Acorn International Reports Third Quarter 2014 Financial Results investment picks
2015/1/21
The Premier British TV Streaming Service in North America will EXCLUSIVELY premiere the epic British period drama starring The Fall and Fifty Shades of Grey star SILVER SPRING, Md., Jan.
Sign-up for Acorn TV's New Miniseries Starring Jamie Dornan New Worlds Makes Its U.S. Debut on Monday, February 16, 2015 investment picks
SAN DIEGO and ALISO VIEJO, Calif.
Sign-up for Acquisition of Avanir Pharmaceuticals, Inc. (AVNR) by Otsuka Pharmaceutical Co., Ltd. May Not Be in Shareholders' Best Interests investment picks
2014/12/29
SAN DIEGO and LAS VEGAS , Dec.
Sign-up for Acquisition of Caesars Acquisition Company (CACQ) by Caesars Entertainment Corporation (CZR) May Not Be in Shareholders' Best Interests investment picks
SAN DIEGO and MELVILLE, N.Y. , Nov.
Sign-up for Acquisition of ChyronHego Corporation (CHYR) by Vector Capital May Not Be in Shareholders' Best Interests investment picks
SAN DIEGO and GREAT NECK, N.Y. , Dec.
Sign-up for Acquisition of Community National Bank (CBNY) by Bridge Bancorp, Inc. (BDGE) May Not Be in Shareholders' Best Interests investment picks
SAN DIEGO and YONKERS, N.Y. , Nov.
Sign-up for Acquisition of Hudson Valley Holding Corp. (HVB) by Sterling Bancorp (STL) May Not Be in Shareholders' Best Interests investment picks
SAN DIEGO and LORAIN, Ohio , Dec.
Sign-up for Acquisition of LNB Bancorp Inc. (LNBB) by Northwest Bancshares Inc. (NWBI) May Not Be in Shareholders' Best Interests investment picks
SAN DIEGO and FREMONT, Calif., Nov.
Sign-up for Acquisition of Oplink Communications, Inc. (OPLK) by Koch Industries, Inc. May Not Be in Shareholders' Best Interests investment picks
SAN DIEGO and SUNNYVALE, Calif.
Sign-up for Acquisition of Spansion Inc. (CODE) by Cypress Semiconductor Corp. (CY) May Not Be in Shareholders' Best Interests investment picks
SAN DIEGO and WORCESTER, Mass., Nov.
Sign-up for Acquisition of World Energy Solutions, Inc. (XWES) by EnerNOC, Inc. (ENOC) May Not Be in Shareholders' Best Interests investment picks
2014/11/12
BENTONVILLE, Ark., Nov.
Sign-up for Acres for America Announces Grant Recipients for 2014 investment picks
- Indicated for Treatment of Moderate to Severe Alzheimer's Disease - DUBLIN and EMERYVILLE, Calif., Dec.
Sign-up for Actavis and Adamas Announce FDA Approval of Namzaric™, a Fixed-Dose Combination of Memantine Extended-Release and Donepezil Hydrochloride investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Acorda Therapeutics to Present at the Stifel 2014 Healthcare Conference to Actavis and Allergan Announce Early Termination of Hart-Scott-Rodino Waiting Period for Actavis' Pending Acquisition of Allergan and Record Dates for Shareholder Meetings
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent